Announcement on Resolutions of the 18th Meeting of the 2nd Board of Directors
Securities code: 688193 Securities abbreviation: Rendu Biotechnology Announcement number: 2026-024
Shanghai Rendu Biotechnology Co., Ltd.
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
The 18th meeting of the second board of directors of Shanghai Rendu Biotechnology Co., Ltd. (hereinafter referred to as the "Company") was held on August 27, 2026 in the conference room on the second floor of the company through on-site voting combined with communication. The meeting notice and meeting materials were sent by email on August 17, 2026. Due to the addition of temporary proposals from the board of directors, supplementary notices and supplementary meeting materials were issued on August 26, 2026. It was sent to all directors by email on the same day, and written confirmation was obtained from all directors that they agreed to add the proposal for the 18th meeting of the second board of directors and hold the meeting as scheduled. There were 7 directors who should be present at the meeting, and 7 directors actually attended the meeting. The directors present accounted for 100% of the number of directors who should be present. The company's senior managers attended the board meeting. The convening and holding procedures of this board meeting complied with the requirements of the company's articles of association and relevant laws and regulations. After deliberation and voting by the directors present at the meeting, the meeting resolved as follows:
- Consideration and adoption of the "Proposal on the Company's 2026 Semi-Annual Report and its Summary" This proposal has been reviewed and approved by the Audit Committee of the Company's Board of Directors.
Voting results: 7 votes in favor, 0 votes against, and 0 abstentions.
This proposal does not need to be submitted to the shareholders' meeting for review.
For details, please see the company’s website on the Shanghai Stock Exchange on August 29, 2026
"2026 Semi-Annual Report" and "2026 Semi-Annual Report Summary" disclosed by (www.sse.com.cn).
- Consideration and approval of the "Proposal on the Company's Special Report on the Deposit, Management and Actual Use of Funds Raised in the Half-Year of 2026"
This proposal has been reviewed and approved by the Audit Committee of the Company's Board of Directors.
Voting results: 7 votes in favor, 0 votes against, and 0 abstentions.
This proposal does not need to be submitted to the shareholders' meeting for review.
For details, please see the company’s website on the Shanghai Stock Exchange on August 29, 2026
(www.sse.com.cn) "Special Report on the Deposit, Management and Actual Use of Raised Funds in the Half-Year 2026" (Announcement Number: 2026-025)
- Consideration and approval of the "Proposal on the Company's "Evaluation Report on the Action Plan of "Improving Quality, Increasing Efficiency and Focusing on Returns" for the First Half of 2026 of Shanghai Rendu Biotechnology Co., Ltd.""
Voting results: 7 votes in favor, 0 votes against, and 0 abstentions.
This proposal does not need to be submitted to the shareholders' meeting for review.
For details, please see the company’s website on the Shanghai Stock Exchange on August 29, 2026
(www.sse.com.cn) "Evaluation Report on the Action Plan of "Improving Quality, Increasing Efficiency and Focusing on Returns" of Shanghai Rendu Biotechnology Co., Ltd. for the first half of 2026 disclosed by (www.sse.com.cn).
- The voting results of the "Proposal on the Company's Establishment of a Securities Investment Management System" were reviewed and approved: 7 votes in favor, 0 votes against, and 0 abstentions.
This proposal does not need to be submitted to the shareholders' meeting for review.
For details, please see the company’s website on the Shanghai Stock Exchange on August 29, 2026
"Securities Investment Management System" disclosed by (www.sse.com.cn).
Announcement is hereby made.
Board of Directors of Shanghai Rendu Biotechnology Co., Ltd.
August 29, 2026